In this work, we sought to elaborate T cell-mediated antitumor effects of tumor-redirected MHC class I-restricted CD4+ T cells in comparison to tumor-redirected CD8+ T cells and inquired possible synergistic effects of both subsets in our in vitro and in vivo models. The gene discussed is CD4; the disease is neoplasm.